RxSight Inc (RXST)
45.55
+0.50
(+1.11%)
USD |
NASDAQ |
Nov 22, 11:58
RxSight Shareholders Equity (Quarterly): 277.26M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 277.26M |
June 30, 2024 | 275.21M |
March 31, 2024 | 163.93M |
December 31, 2023 | 160.36M |
September 30, 2023 | 161.48M |
June 30, 2023 | 157.19M |
March 31, 2023 | 145.01M |
December 31, 2022 | 89.90M |
Date | Value |
---|---|
September 30, 2022 | 95.96M |
June 30, 2022 | 109.99M |
March 31, 2022 | 123.16M |
December 31, 2021 | 138.24M |
September 30, 2021 | 150.89M |
June 30, 2021 | -313.40M |
March 31, 2021 | -301.90M |
December 31, 2020 | -297.53M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-313.40M
Minimum
Jun 2021
277.26M
Maximum
Sep 2024
70.98M
Average
141.63M
Median
Shareholders Equity (Quarterly) Benchmarks
Tandem Diabetes Care Inc | 237.71M |
Perspective Therapeutics Inc | 328.47M |
Retractable Technologies Inc | 83.46M |
Xtant Medical Holdings Inc | 45.72M |
Catheter Precision Inc | 12.83M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 310.47M |
Total Liabilities (Quarterly) | 33.21M |
Current Ratio | 12.67 |
Net Debt Paydown Yield | 0.20% |